The AGMH & Sheltowee Venture Fund II is the successor to a successful Fund I that was closed earlier this year. The fund has 15 companies in its portfolio, which are making moves to raise additional capital at higher valuations. The fund also builds on the Angel Capital Group Fund II efforts from 2013 – 2022 with a robust portfolio, several notable exits, and appropriate venture-sized returns.
The fund is targeting medical devices, health tech, life sciences, advanced materials, additive manufacturing, SaaS, cleantech, and fintech sectors, where the team has a demonstrated track record of success.
Share with friends